Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
59th of 267 in
Neurosciences
-
33rd of 267 in
Pharmacology & Pharmacy
Aims & Scope
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Current Neuropharmacology
,Volume 17
-Number 10
Biography Open Access
Meet Our Editorial Board Member
Perspective Open Access
Recent Advances in Epilepsy
, 17(10): 914 - 915Yang Jin, Xiaoxiao Yao, Lihua Sun, Wei Yang, Ranji Cui and Bingjin Li*
DOI: 10.2174/1570159X1710190911122554
Recent Advances in Epilepsy
Systemic Review Article
Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
, 17(10): 916 - 925Danielly Chierrito, Camila B. Villas-Boas, Fernanda S. Tonin, Fernando Fernandez-Llimos, Andréia C.C. Sanches and João C.P. de Mello*
DOI: 10.2174/1570159X17666190409143155
Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Review Article
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
, 17(10): 926 - 946Michele Romoli, Petra Mazzocchetti, Renato D'Alonzo, Sabrina Siliquini, Victoria Elisa Rinaldi, Alberto Verrotti, Paolo Calabresi and Cinzia Costa*
DOI: 10.2174/1570159X17666181227165722
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Review Article
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
, 17(10): 947 - 960Ricardo E. Ramírez-Orozco, Ricardo García-Ruiz, Paula Morales, Carlos M. Villalón, J. Rafael Villafán-Bernal and Bruno A. Marichal-Cancino*
DOI: 10.2174/1570159X17666190118143014
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Review Article
Mouse Models of Familial Hemiplegic Migraine for Studying Migraine Pathophysiology
, 17(10): 961 - 973Anisa Dehghani and Hulya Karatas*
DOI: 10.2174/1570159X17666190513085013
Mouse Models of Familial Hemiplegic Migraine for Studying Migraine Pathophysiology
Review Article
Cannabidiol Adverse Effects and Toxicity
, 17(10): 974 - 989Marilyn A. Huestis, Renata Solimini, Simona Pichini, Roberta Pacifici, Jeremy Carlier and Francesco Paolo Busardò*
DOI: 10.2174/1570159X17666190603171901
Cannabidiol Adverse Effects and Toxicity
Review Article
Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders
, 17(10): 990 - 1002Naveen Sharma , Eun-Joo Shin, Nam Hun Kim , Eun-Hee Cho, Bao Trong Nguyen, Ji Hoon Jeong , Choon Gon Jang , Seung-Yeol Nah and Hyoung-Chun Kim*
DOI: 10.2174/1570159X17666190228114318
Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders
Articles Ahead of Print
Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Nina Japundžić-Žigon*, Maja Lozić, Olivera Šarenac and David Murphy
DOI: 10.2174/1570159X17666190717150501
View Abstract
Neuro-toxic and Reproductive Effects of BPA
Antonietta Santoro, Rosanna Chianese, Jacopo Troisi, Sean Richards, Stefania Lucia Nori, Silvia Fasano, Maurizio Guida, Elizabeth Plunck, Andrea Viggiano, Riccardo Pierantoni and Rosaria Meccariello*
DOI: 10.2174/1570159X17666190726112101
View Abstract View on PubMed
The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Sari Goldstein Ferber*, Dvora Namdar*, Danielle Hen-Shoval, Gilad Eger, Hinanit Koltai, Gal Shoval, Liat Shbiro and Aron Weller
DOI: 10.2174/1570159X17666190903103923
View Abstract View on PubMed
Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery
Rafał Szelenberger, Joanna Kostka, Joanna Saluk-Bijak and Elżbieta Miller*
DOI: 10.2174/1570159X17666190726104139
View Abstract View on PubMed
Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression
Darakhshan Jabeen Haleem*
DOI: 10.2174/1570159X17666190811161807
View Abstract View on PubMed
Zinc-mediated Neurotransmission in Alzheimer’s Disease: A Potential Role of the GPR39 in Dementia
Michal Rychlik* and Katarzyna Mlyniec
DOI: 10.2174/1570159X17666190704153807
View Abstract View on PubMed
Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases
Ling-Shuang Zhu, Ding-Qi Wang, Ke Cui, Dan Liu* and Ling-Qiang Zhu
DOI: 10.2174/1570159X17666190726115623
View Abstract View on PubMed
The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
Serena Boccella, Ida Marabese, Francesca Guida, Livio Luongo, Sabatino Maione and Enza Palazzo*
DOI: 10.2174/1570159X17666190618121859
View Abstract View on PubMed
Cocaine-induced Changes in the Expression of NMDA Receptor Subunits
Irena Smaga*, Marek Sanak and Małgorzata Filip
DOI: 10.2174/1570159X17666190617101726
View Abstract View on PubMed
Highlighting the Role of Cognitive and Brain Reserve in the Substance use Disorder Field
D. Cutuli, D. Ladrón de Guevara-Miranda, E. Castilla-Ortega, L.J. Santín* and P. Sampedro-Piquero*
DOI: 10.2174/1570159X17666190617100707
View Abstract View on PubMed
Abstracts Ahead of Print
Dietary flavonoids interaction with CREB-BDNF pathway: An unconventional approach for comprehensive management of epilepsy
Pallavi Sharma, Amit Kumar and Damanpreet Singh*
DOI: 10.2174/1570159X17666190809165549
View Abstract
The Endocannabinoid System May Modulate Sleep Disorders In Aging
Eric Murillo-Rodríguez, Henning Budde, André Barciela Veras*, Nuno Barbosa Rocha, Diogo Telles-Correia, Diogo Monteiro, Luis Cid, Tetsuya Yamamoto, Sérgio Machado and Pablo Torterolo
DOI: 10.2174/1570159X17666190801155922
View Abstract
Published Contents
- Current Neuropharmacology, Volume 17, 2019
-
Current Neuropharmacology, Volume 16, 2018
- Issue number 10
- Issue number 9 [Thematic Issue]
- Issue number 8 [Thematic Issue]
- Issue number 7 [Thematic Issue]
- Issue number 6 [Thematic Issue]
- Issue number 5 [Thematic Issue]
- Issue number 4 [Thematic Issue]
- Issue number 3 [Thematic Issue]
- Issue number 2
- Issue number 1 - Free Issue [Thematic Issue]
- Issue number 1
- Current Neuropharmacology, Volume 15, 2017
- Current Neuropharmacology, Volume 14, 2016
- Current Neuropharmacology, Volume 13, 2015
- Current Neuropharmacology, Volume 12, 2014
- Current Neuropharmacology, Volume 11, 2013
- Current Neuropharmacology, Volume 10, 2012
- Current Neuropharmacology, Volume 9, 2011
- Current Neuropharmacology, Volume 8, 2010
- Current Neuropharmacology, Volume 7, 2009
- Current Neuropharmacology, Volume 6, 2008
- Current Neuropharmacology, Volume 5, 2007
- Current Neuropharmacology, Volume 4, 2006
- Current Neuropharmacology, Volume 3, 2005
- Current Neuropharmacology, Volume 2, 2004
- Current Neuropharmacology, Volume 1, 2003
Editor's Choice
Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
, 2019; 17(10): 916 - 925Danielly Chierrito, Camila B. Villas-Boas, Fernanda S. Tonin, Fernando Fernandez-Llimos, Andréia C.C. Sanches and João C.P. de Mello*
DOI: 10.2174/1570159X17666190409143155
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
, 2019; 17(9): 861 - 873Marika Alborghetti and Ferdinando Nicoletti*
DOI: 10.2174/1570159X16666180830100754
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
, 2019; 17(8): 710 - 736Antonio Del Casale*, Serena Sorice, Alessio Padovano, Maurizio Simmaco, Stefano Ferracuti, Dorian A. Lamis, Chiara Rapinesi, Gabriele Sani, Paolo Girardi, Georgios D. Kotzalidis and Maurizio Pompili
DOI: 10.2174/1570159X16666180813155017
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
, 2019; 17(6): 550 - 562Shilpa Sharma and Ravi S. Akundi*
DOI: 10.2174/1570159X16666180302120322
Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
, 2019; 17(5): 422 - 437David Agustín León-Navarro, José Luis Albasanz and Mairena Martín*
DOI: 10.2174/1570159X16666180416093717
NGF and BDNF Alterations by Prenatal Alcohol Exposure
, 2019; 17(4): 308 - 317Valentina Carito, Mauro Ceccanti, Giampiero Ferraguti, Roberto Coccurello, Stefania Ciafrè, Paola Tirassa and Marco Fiore*
DOI: 10.2174/1570159X15666170825101308
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
, 2019; 17(3): 295 - 306Iván Carrera* and Ramón Cacabelos
DOI: 10.2174/1570159X17666181127125704
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
, 2019; 17(2): 176 - 183Giuseppina Talarico*, Alessandro Trebbastoni, Giuseppe Bruno and Carlo de Lena
DOI: 10.2174/1570159X16666180702144644
Statins and the Brain: More than Lipid Lowering Agents?
, 2019; 17(1): 59 - 83Anna Fracassi , Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni and Marco Segatto*
DOI: 10.2174/1570159X15666170703101816
Nerve Growth Factor: Early Studies and Recent Clinical Trials
, 2018; 16(10): 1455 - 1465Maria Luisa Rocco, Marzia Soligo, Luigi Manni and Luigi Aloe*
DOI: 10.2174/1570159X16666180412092859
Open Access Articles
Application of the Co-Agonist Concerted Transition Model to Analysis of GABAA Receptor Properties
, 2019; 17(9): 843 - 851Allison L. Germann, Joe Henry Steinbach and Gustav Akk*
Evolving Mechanistic Concepts of Epileptiform Synchronization and their Relevance in Curing Focal Epileptic Disorders
, 2019; 17(9): 830 - 842Maxime Lévesque, David Ragsdale and Massimo Avoli*
Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
, 2019; 17(9): 823 - 829Michel Baudry*
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
, 2019; 17(6): 539 - 549Bo Wang and Xiao-Ping Wang*
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
, 2019; 17(2): 108 - 128Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker*
Relevance of CYP2C9 Function in Valproate Therapy
, 2019; 17(1): 99 - 106Katalin Monostory*, Andrea Nagy, Katalin Tóth, Tamás Bűdi , Ádám Kiss, Máté Déri and Gábor Csukly
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
, 2019; 17: 1 - 17 (E-Pub Ahead of Print)Estefania Gastaldello Moreira*, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello and Michael Maes
Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury
, 2018; 16(9): 1358 - 1364Di Li, Haibo Ni, Qin Rui, Rong Gao* and Gang Chen
The Role of IRE1 Signaling in the Central Nervous System Diseases
, 2018; 16(9): 1340 - 1347Haibo Ni, Qin Rui, Di Li*, Rong Gao and Gang Chen
Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System
, 2018; 16(4): 460 - 474Hikaru Takeuchi* and Ryuta Kawashima
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
, 2016; 14(7): 721 - 731Ji-chun Zhang, Wei Yao and Kenji Hashimoto
Animal Models of Maternal Immune Activation in Depression Research
, 2016; 14(7): 688 - 704Marianne Ronovsky, Stefanie Berger, Barbara Molz, Angelika Berger and Daniela D. Pollak
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
, 2016; 14(4): 314 - 321Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
, 2016; 14(4): 307 - 313Feng Wang, Ting-Yi Feng, Shilin Yang, Maurice Preter, Jiang-Ning Zhou and Xiao-Ping Wang
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
, 2016; 14(4): 302 - 306Li-Li Zhang, S. Duff Canning and Xiao-Ping Wang
Most Cited Articles
Review Article
New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: A focus on α7 nAChRs
, 2018; 16(4): 415-425.Deniz Bagdas*, Mine S. Gurun, Pamela Flood, Roger L. Papke and M. Imad Damaj
DOI: 10.2174/1570159X15666170818102108
Review Article
Imaging the role of inflammation in mood and anxiety-related disorders
, 2018; 16(5): 533-558.Jennifer C. Felger*
DOI: 10.2174/1570159X15666171123201142
General Review Article
Levodopa in parkinson’s disease: Current status and future developments
, 2018; 16(8): 1239-1252.Nicola Tambasco*, Michele Romoli and Paolo Calabresi
DOI: 10.2174/1570159X15666170510143821
Review Article
Cognitive effects of nicotine: Recent progress
, 2018; 16(4): 403-414.Gerald Valentine and Mehmet Sofuoglu*
DOI: 10.2174/1570159X15666171103152136
Review Article
The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases
, 1 January 2018; 16(1): 403-414.Gerald Valentine and Mehmet Sofuoglu*
DOI: 10.2174/1570159X15666170529104323
General Review Article
Recent advances in pathophysiology of traumatic brain injury
, 2018; 16(8): 1224-1238.Parmeet Kaur and Saurabh Sharma*
DOI: 10.2174/1570159X15666170613083606
Review Article
Neural network alterations across eating disorders: A narrative review of fMRI studies
, 2018; 16(8): 1150-1163.Trevor Steward, Jose M. Menchon, Susana Jiménez-Murcia, Carles Soriano-Mas* and Fernando Fernandez-Aranda*
DOI: 10.2174/1570159X15666171017111532
Review Article
Therapeutic strategies for treatment of inflammation-related depression
, 1 March 2018; 16(2): 176-209.Miroslav Adzic*, Zeljka Brkic, Milos Mitic, Ester Francija, Milica J. Jovicic, Jelena Radulovic and Nadja P. Maric
DOI: 10.2174/1570159X15666170828163048
Review Article
E-cigarettes: Impact of e-liquid components and device characteristics on nicotine exposure
, 2018; 16(4): 438-459.Elise E. DeVito* and Suchitra Krishnan-Sarin
DOI: 10.2174/1570159X15666171016164430
Review Article
Neuronal and extraneuronal nicotinic acetylcholine receptors
, 2018; 16(4): 338-349.Michele Zoli, Susanna Pucci, Antonietta Vilella and Cecilia Gotti*
DOI: 10.2174/1570159X15666170912110450
Review Article
Effects of resveratrol and other polyphenols on SIRT1: Relevance to brain function during aging
, 1 March 2018; 16(2): 126-136.F. Sarubbo , S. Esteban , A. Miralles and D. Moranta *
DOI: 10.2174/1570159X15666170703113212
Review Article
Trp channels as novel targets for endogenous ligands: Focus on endocannabinoids and nociceptive signalling
, 2018; 16(2): 137-150.Maksim V. Storozhuk* and Alexander V. Zholos*
DOI: 10.2174/1570159X15666170424120802
Review Article
3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors
, 2018; 16(6): 881-900.Priyanka Dhiman, Neelam Malik and Anurag Khatkar*
DOI: 10.2174/1570159X15666171128143650
Review Article
Programmed cell death after intracerebral hemorrhage
, 2018; 16(9): 1267-1281.Tobias Bobinger, Petra Burkardt, Hagen B. Huttner and Anatol Manaenko*
DOI: 10.2174/1570159X15666170602112851
Systemic Review Article
Suicide risk in obsessive-compulsive disorder and exploration of risk factors: A systematic review
, 2019; 17(8): 681-696.Umberto Albert *, Diana De Ronchi , Giuseppe Maina and Maurizio Pompili
DOI: 10.2174/1570159X16666180620155941
Most Accessed Articles
Cannabidiol Adverse Effects and Toxicity
, 2019; 17(10): 974-989.Marilyn A. Huestis, Renata Solimini, Simona Pichini, Roberta Pacifici, Jeremy Carlier and Francesco Paolo Busardò*
DOI: 10.2174/1570159X17666190603171901
Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review
, 2019; 17(8): 787-807.Chiara Rapinesi*, Georgios D. Kotzalidis, Stefano Ferracuti, Gabriele Sani, Paolo Girardi and Antonio Del Casale
DOI: 10.2174/1570159X17666190409142555
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
, 2019; 17(2): 108-128.Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker*
DOI: 10.2174/1570159X16666180125095902
School-based Prevention for Adolescent Internet Addiction: Prevention is the Key. A Systematic Literature Review
, 2019; 17(6): 507-525.Melina A. Throuvala*, Mark D. Griffiths, Mike Rennoldson and Daria J. Kuss
DOI: 10.2174/1570159X16666180813153806
Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
, 2019; 17(6): 563-579.Dahua Fan, Liping Liu, Zhengzhi Wu* and Meiqun Cao*
DOI: 10.2174/1570159X16666180419141613
Systematic Review of Food Addiction as Measured with the Yale Food Addiction Scale: Implications for the Food Addiction Construct
, 2019; 17(6): 526-538.Louise Penzenstadler*, Carina Soares, Laurent Karila and Yasser Khazaal
DOI: 10.2174/1570159X16666181108093520
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
, 2019; 17(6): 539-549.Bo Wang and Xiao-Ping Wang*
DOI: 10.2174/1570159X16666180508113025
Towards a Dynamic Exploration of Vision, Cognition and Emotion in Alcohol-Use Disorders
, 2019; 17(6): 492-506.Coralie Creupelandt, Fabien D'Hondt and Pierre Maurage*
DOI: 10.2174/1570159X16666180828100441
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
, 2019; 17(6): 550-562.Shilpa Sharma and Ravi S. Akundi*
DOI: 10.2174/1570159X16666180302120322
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
View Full Editorial Board
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
Biography of T.E. Salt
Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.
Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Scopus CiteScore Metrics: 2.17
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net